Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Bill and Melinda Gates Foundation

- PMLiVE

EU recommendations for Gilead, Ariad and Baxter drugs

EMA backs use of HyQvia, Iclusig and Stribild

- PMLiVE

Gilead settles patent dispute with Teva over Viread generic

Launch of generic HIV drug held back until December 2017

- PMLiVE

Anker Lundemose appointed CEO of Bionor Pharma

Will lead efforts to develop and commercialise HIV vaccines

- PMLiVE

Sexual health apps fail to attract smartphone users

HIV and STD apps not fulfilling their potential to assist with prevention and care

- PMLiVE

ViiV submits dolutegravir for approval to treat HIV in US, EU and Canada

GSK-Pfizer joint venture takes next step towards commercialisation

- PMLiVE

Streaming Well and Terrence Higgins Trust launch HIV education series

Online videos target young people in Britain

- PMLiVE

Efforts to curb HIV must be stepped up, says report

HIV/AIDS advocacy group ONE pushes for more funding to end epidemic

- PMLiVE

Former PEPFAR head Mark Dybul to lead the Global Fund

Joins at time of change for the AIDS, tuberculosis and malaria focused non-profit organisation

- PMLiVE

Global Fund sacks inspector general, moves to new funding model

Also brings in former US global AIDS coordinator Mark Dybul as executive director

- PMLiVE

GSK’s malaria vaccine effects ‘modest’ in infants

Less than expected efficacy findings surprise researchers

- PMLiVE

Malaria charity calls up Ladbury PR to handle comms

Comes as Malaria No More UK partners with ITV’s I’m A Celebrity…Get Me Out Of Here

- PMLiVE

Gilead advances HIV drug into phase III

The treatment is a chemical variant of Gilead's successful HIV drug Viread

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links